Daemon College alumnus elected to board of biotechnology company


Employment of biological scientists is projected to grow 21 percent over the next several years, which is much faster than the average for all other occupations, according to the U.S. Bureau of Labor Statistics. As research and development continues to drive job growth, pharmaceutical and other firms will have a need for biological scientists.

For example, Thomas P. Koestler, a graduate of Daemen College, was appointed to board of directors of Momenta Pharmaceuticals, a biotechnology company. Koestler who serves as Executive-in-Residence at Vatera Holdings, a pharmaceuticals venture capital firm, was also the former executive vice president of Schering-Plough, a pharmaceutical company.

"Tom has an exceptionally strong background in global pharmaceutical research and development and has been associated with over 80 product approvals during his career," said Craig Wheeler, president and CEO of Momenta. "His product development experience and strong record of regulatory success will be a great asset to Momenta as we advance our existing pipeline and move forward with our follow-on biologics program."

Koestler holds a bachelor's of science degree in biology and genetics from Daemon College as well as a PhD in medicine and pathology.

Leave a Comment

Your email address will not be published.